Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker TRDA
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 amended | 5AM Ventures V, L.P. Affiliated stockholder | TRDA Entrada Therapeutics, Inc. | 165,578 | $1.1M | — | Jul 30, 2026 | Form 4 ↗ same day · 52,317 shares | Form 144/A ↗ |
| Aug 10, 2026 amended | 5AM Ventures V, L.P. Affiliated stockholder | TRDA Entrada Therapeutics, Inc. | 165,578 | $1.1M | — | Jul 30, 2026 | Form 4 ↗ same day · 52,317 shares | Form 144/A ↗ |
| Jul 30, 2026 | 5AM Ventures V, L.P. Affiliated stockholder | TRDA Entrada Therapeutics, Inc. | 331,156 | $2.2M | — | Jul 30, 2026 | Form 4 ↗ 4 days later · 116,474 shares | Form 144 ↗ |
| May 4, 2026 | Nathan Dowden Officer | TRDA Entrada Therapeutics, Inc. | 15,000 | $217.5K | 10b5-1 | May 4, 2026 | Form 4 ↗ same day · 15,000 shares | Form 144 ↗ |
| May 4, 2026 | Natarajan Sethuraman Officer | TRDA Entrada Therapeutics, Inc. | 25,907 | $375.7K | 10b5-1 | May 4, 2026 | Form 4 ↗ same day · 25,907 shares | Form 144 ↗ |
| Apr 1, 2026 | Kory Wentworth Officer | TRDA Entrada Therapeutics, Inc. | 2,500 | $31.6K | 10b5-1 | Apr 1, 2026 | Form 4 ↗ 1 day later · 2,500 shares | Form 144 ↗ |
| Mar 9, 2026 | Kory Wentworth Officer | TRDA Entrada Therapeutics, Inc. | 16,477 | $207.3K | 10b5-1 | Mar 9, 2026 | Form 4 ↗ 2 days later · 16,477 shares | Form 144 ↗ |
| Mar 9, 2026 | Nathan Dowden Officer | TRDA Entrada Therapeutics, Inc. | 15,010 | $188.8K | 10b5-1 | Mar 9, 2026 | Form 4 ↗ 2 days later · 15,010 shares | Form 144 ↗ |
| Mar 4, 2026 | Kory Wentworth Officer | TRDA Entrada Therapeutics, Inc. | 7,988 | $94.7K | 10b5-1 | Mar 4, 2026 | Form 4 ↗ 2 days later · 7,988 shares | Form 144 ↗ |
| Nov 21, 2025 | Kory Wentworth Officer | TRDA Entrada Therapeutics, Inc. | 8,910 | $81.7K | 10b5-1 | Nov 21, 2025 | Form 4 ↗ 3 days later · 8,910 shares | Form 144 ↗ |
| Nov 14, 2025 | 5AM Ventures V, L.P. Affiliated Stockholder | TRDA Entrada Therapeutics, Inc. | 200,000 | $1.8M | — | Nov 14, 2025 | Form 4 ↗ 4 days later · 200,000 shares | Form 144 ↗ |
| Jul 9, 2025 | 5AM Opportunities I, L.P. Director | TRDA Entrada Therapeutics, Inc. | 6,935 | $52.0K | — | Jul 9, 2025 | Form 4 ↗ 2 days later · 27,000 shares | Form 144 ↗ |
| Jul 9, 2025 | 5AM Ventures V, L.P. Director | TRDA Entrada Therapeutics, Inc. | 20,065 | $150.5K | — | Jul 9, 2025 | Form 4 ↗ 2 days later · 27,000 shares | Form 144 ↗ |
| Jul 1, 2025 | 5AM Ventures V, L.P. Director | TRDA Entrada Therapeutics, Inc. | 18,578 | $132.3K | — | Jul 1, 2025 | Form 4 ↗ same day · 50,000 shares | Form 144 ↗ |
| Jul 1, 2025 | 5AM Opportunities I, L.P. Director | TRDA Entrada Therapeutics, Inc. | 6,422 | $45.7K | — | Jul 1, 2025 | Form 4 ↗ same day · 50,000 shares | Form 144 ↗ |
| Jun 30, 2025 | 5AM Opportunities I, L.P. Director | TRDA Entrada Therapeutics, Inc. | 6,422 | $43.8K | — | Jun 30, 2025 | Form 4 ↗ 1 day later · 125,000 shares | Form 144 ↗ |
| Jun 30, 2025 | 5AM Ventures V, L.P. Director | TRDA Entrada Therapeutics, Inc. | 18,578 | $126.6K | — | Jun 30, 2025 | Form 4 ↗ 1 day later · 125,000 shares | Form 144 ↗ |
| Jun 27, 2025 | 5AM Opportunities I, L.P. Director | TRDA Entrada Therapeutics, Inc. | 19,265 | $133.1K | — | Jun 27, 2025 | Form 4 ↗ 4 days later · 125,000 shares | Form 144 ↗ |
| Jun 27, 2025 | 5AM Ventures V, L.P. Director | TRDA Entrada Therapeutics, Inc. | 55,735 | $385.1K | — | Jun 27, 2025 | Form 4 ↗ 4 days later · 125,000 shares | Form 144 ↗ |
| Mar 17, 2025 | Kory Wentworth Officer | TRDA Entrada Therapeutics, Inc. | 1,784 | $19.3K | 10b5-1 | Mar 17, 2025 | Form 4 ↗ 2 days later · 1,784 shares | Form 144 ↗ |
| Nov 12, 2024 | Natarajan Sethuraman Officer | TRDA Entrada Therapeutics, Inc. | 18,762 | $371.9K | 10b5-1 | Nov 11, 2024 | Form 4 ↗ 1 day later · 4,109 shares | Form 144 ↗ |
| Nov 12, 2024 | Kory Wentworth Officer | TRDA Entrada Therapeutics, Inc. | 14,637 | $290.1K | 10b5-1 | Nov 11, 2024 | Form 4 ↗ 21 days later · 6,000 shares | Form 144 ↗ |
| Oct 16, 2024 | Natarajan Sethuraman Officer | TRDA Entrada Therapeutics, Inc. | 20,057 | $351.6K | 10b5-1 | Oct 16, 2024 | Form 4 ↗ 2 days later · 600 shares | Form 144 ↗ |
| Sep 9, 2024 | Kory Wentworth Officer | TRDA Entrada Therapeutics, Inc. | 3,195 | $47.3K | 10b5-1 | Sep 9, 2024 | Form 4 ↗ 65 days later · 8,637 shares | Form 144 ↗ |
| Sep 6, 2024 | Nathan Dowden Officer | TRDA Entrada Therapeutics, Inc. | 3,150 | $48.5K | 10b5-1 | Sep 6, 2024 | — | Form 144 ↗ |
| Aug 16, 2024 | Nathan Dowden Officer | TRDA Entrada Therapeutics, Inc. | 27,097 | $440.6K | 10b5-1 | Aug 16, 2024 | — | Form 144 ↗ |
| Jul 15, 2024 | Dipal Doshi Officer | TRDA Entrada Therapeutics, Inc. | 14,238 | $244.2K | 10b5-1 | Jul 15, 2024 | — | Form 144 ↗ |
| Jul 12, 2024 | Natarajan Sethuraman Officer | TRDA Entrada Therapeutics, Inc. | 20,057 | $348.4K | 10b5-1 | Jul 12, 2024 | — | Form 144 ↗ |
| Jul 8, 2024 | Kory Wentworth Officer | TRDA Entrada Therapeutics, Inc. | 1,758 | $24.8K | 10b5-1 | Jul 8, 2024 | — | Form 144 ↗ |
| Jun 13, 2024 | Dipal Doshi Director, Officer | TRDA Entrada Therapeutics, Inc. | 2,000 | $31.8K | 10b5-1 | Jun 13, 2024 | — | Form 144 ↗ |
| May 16, 2024 | Natarajan Sethuraman Officer | TRDA Entrada Therapeutics, Inc. | 18,980 | $275.0K | 10b5-1 | May 16, 2024 | — | Form 144 ↗ |
| May 16, 2024 | Dipal Doshi Director, Officer | TRDA Entrada Therapeutics, Inc. | 3,000 | $43.5K | 10b5-1 | May 16, 2024 | — | Form 144 ↗ |
| Apr 30, 2024 | Nerissa C Kreher Officer | TRDA Entrada Therapeutics, Inc. | 1,200 | $14.6K | — | Apr 30, 2024 | — | Form 144 ↗ |
| Apr 29, 2024 | Nerissa C Kreher Officer | TRDA Entrada Therapeutics, Inc. | 13,729 | $168.5K | — | Apr 29, 2024 | — | Form 144 ↗ |
| Apr 26, 2024 | Nerissa C Kreher Officer | TRDA Entrada Therapeutics, Inc. | 3,400 | $42.5K | — | Apr 26, 2024 | — | Form 144 ↗ |
| Apr 25, 2024 | Nerissa C Kreher Officer | TRDA Entrada Therapeutics, Inc. | 12,483 | $152.5K | — | Apr 25, 2024 | — | Form 144 ↗ |
| Apr 24, 2024 | Nerissa C Kreher Officer | TRDA Entrada Therapeutics, Inc. | 3,791 | $47.4K | — | Apr 24, 2024 | — | Form 144 ↗ |
| Apr 23, 2024 | Nerissa C Kreher Officer | TRDA Entrada Therapeutics, Inc. | 5,402 | $71.4K | — | Apr 23, 2024 | — | Form 144 ↗ |
| Apr 19, 2024 | Nerissa C Kreher Officer | TRDA Entrada Therapeutics, Inc. | 9,632 | $116.2K | — | Apr 19, 2024 | — | Form 144 ↗ |
| Apr 18, 2024 | Nerissa C Kreher Officer | TRDA Entrada Therapeutics, Inc. | 9,311 | $112.7K | — | Apr 18, 2024 | — | Form 144 ↗ |
| Apr 17, 2024 | Nerissa C Kreher Officer | TRDA Entrada Therapeutics, Inc. | 6,977 | $86.4K | — | Apr 17, 2024 | — | Form 144 ↗ |
| Apr 16, 2024 | Nerissa C Kreher Officer | TRDA Entrada Therapeutics, Inc. | 6,603 | $84.2K | — | Apr 16, 2024 | — | Form 144 ↗ |
| Apr 15, 2024 | Nerissa C Kreher Officer | TRDA Entrada Therapeutics, Inc. | 3,952 | $51.1K | — | Apr 15, 2024 | — | Form 144 ↗ |
| Apr 12, 2024 | Nerissa C Kreher Officer | TRDA Entrada Therapeutics, Inc. | 3,542 | $47.0K | — | Apr 12, 2024 | — | Form 144 ↗ |
| Apr 11, 2024 | Nerissa C Kreher Officer | TRDA Entrada Therapeutics, Inc. | 8,510 | $110.1K | — | Apr 11, 2024 | — | Form 144 ↗ |
| Apr 10, 2024 | Nerissa C Kreher Officer | TRDA Entrada Therapeutics, Inc. | 14,096 | $176.0K | — | Apr 10, 2024 | — | Form 144 ↗ |
| Apr 9, 2024 | Nerissa C Kreher Officer | TRDA Entrada Therapeutics, Inc. | 8,163 | $108.0K | — | Apr 9, 2024 | — | Form 144 ↗ |
| Apr 8, 2024 | Nerissa C Kreher Officer | TRDA Entrada Therapeutics, Inc. | 5,689 | $76.8K | — | Apr 8, 2024 | — | Form 144 ↗ |
| Apr 5, 2024 | Nerissa C Kreher Officer | TRDA Entrada Therapeutics, Inc. | 7,500 | $102.6K | — | Apr 5, 2024 | — | Form 144 ↗ |
| Mar 6, 2024 | Nathan Dowden Officer | TRDA Entrada Therapeutics, Inc. | 1,826 | $22.4K | 10b5-1 | Mar 6, 2024 | — | Form 144 ↗ |
The newest 50 items, most recent first. Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 7:22 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances